Caissa Capital Management Ltd. - Net Worth and Insider Trading
Caissa Capital Management Ltd. Net Worth
The estimated net worth of Caissa Capital Management Ltd. is at least $76,592 dollars as of 2024-05-10. Caissa Capital Management Ltd. is the 10% Owner of Avalo Therapeutics Inc and owns about 6,666 shares of Avalo Therapeutics Inc (AVTX) stock worth over $76,592. Details can be seen in Caissa Capital Management Ltd.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Caissa Capital Management Ltd. has not made any transactions after 2023-06-14 and currently still holds the listed stock(s).
Transaction Summary of Caissa Capital Management Ltd.
Caissa Capital Management Ltd. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Caissa Capital Management Ltd. owns 1 companies in total, including Avalo Therapeutics Inc (AVTX) .
Click here to see the complete history of Caissa Capital Management Ltd.’s form 4 insider trades.
Insider Ownership Summary of Caissa Capital Management Ltd.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AVTX | Avalo Therapeutics Inc | 2023-06-14 | 10 percent owner |
Caissa Capital Management Ltd. Latest Holdings Summary
Caissa Capital Management Ltd. currently owns a total of 1 stock. Caissa Capital Management Ltd. owns 6,666 shares of Avalo Therapeutics Inc (AVTX) as of June 14, 2023, with a value of $76,592.
Latest Holdings of Caissa Capital Management Ltd.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AVTX | Avalo Therapeutics Inc | 2023-06-14 | 6,666 | 11.49 | 76,592 |
Holding Weightings of Caissa Capital Management Ltd.
Caissa Capital Management Ltd. Form 4 Trading Tracker
According to the SEC Form 4 filings, Caissa Capital Management Ltd. has made a total of 12 transactions in Avalo Therapeutics Inc (AVTX) over the past 5 years, including 12 buys and 0 sells. The most-recent trade in Avalo Therapeutics Inc is the acquisition of 70 shares on June 14, 2023, which cost Caissa Capital Management Ltd. around $63,709.
Insider Trading History of Caissa Capital Management Ltd.
- 1
Caissa Capital Management Ltd. Trading Performance
GuruFocus tracks the stock performance after each of Caissa Capital Management Ltd.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Caissa Capital Management Ltd. is -93.98%. GuruFocus also compares Caissa Capital Management Ltd.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Caissa Capital Management Ltd. within 3 months outperforms 0 times out of 12 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Caissa Capital Management Ltd.'s insider trading performs compared to the benchmark.
Performance of Caissa Capital Management Ltd.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -14.57 | | | | | |
| Relative Return to S&P 500(%) | -18.04 | | | | | |
Caissa Capital Management Ltd. Ownership Network
Caissa Capital Management Ltd. Owned Company Details
What does Avalo Therapeutics Inc do?
Who are the key executives at Avalo Therapeutics Inc?
Caissa Capital Management Ltd. is the 10 percent owner of Avalo Therapeutics Inc. Other key executives at Avalo Therapeutics Inc include director & 10 percent owner Armistice Capital Master Fund Ltd. , Interim CFO Christopher Ryan Sullivan , and Chief Medical Officer Garry Arthur Neil .
Avalo Therapeutics Inc (AVTX) Insider Trades Summary
Over the past 18 months, Caissa Capital Management Ltd. made 12 insider transaction in Avalo Therapeutics Inc (AVTX) with a net purchase of 206,169. Other recent insider transactions involving Avalo Therapeutics Inc (AVTX) include a net sale of 3,233,542 shares made by Armistice Capital Master Fund Ltd. , a net purchase of 6,083 shares made by Garry Arthur Neil , and a net purchase of 511 shares made by Christopher Ryan Sullivan .
In summary, during the past 3 months, insiders sold 0 shares of Avalo Therapeutics Inc (AVTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 15,348 shares of Avalo Therapeutics Inc (AVTX) were sold and 2,762 shares were bought by its insiders, resulting in a net sale of 12,587 shares.
Avalo Therapeutics Inc (AVTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Avalo Therapeutics Inc Insider Transactions
Caissa Capital Management Ltd. Mailing Address
Above is the net worth, insider trading, and ownership report for Caissa Capital Management Ltd.. You might contact Caissa Capital Management Ltd. via mailing address: Palm Grove House, Wickhams Cay 1 Road Town, Tortola D8 Vg1110.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
